- Home
- SURG vs ABVC Comparison
SURG vs ABVC Comparison
Compare SURG & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- ABVC
- Stock Information
- Founded
- SURG 2006
- ABVC 2015
- Country
- SURG United States
- ABVC United States
- Employees
- SURG N/A
- ABVC N/A
- Industry
- SURG Advertising
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- ABVC Health Care
- Exchange
- SURG Nasdaq
- ABVC Nasdaq
- Market Cap
- SURG 58.6M
- ABVC 52.1M
- IPO Year
- SURG N/A
- ABVC N/A
- Fundamental
- Price
- SURG $2.71
- ABVC $2.96
- Analyst Decision
- SURG Strong Buy
- ABVC
- Analyst Count
- SURG 1
- ABVC 0
- Target Price
- SURG $9.50
- ABVC N/A
- AVG Volume (30 Days)
- SURG 93.8K
- ABVC 106.9K
- Earning Date
- SURG 11-11-2025
- ABVC 11-13-2025
- Dividend Yield
- SURG N/A
- ABVC N/A
- EPS Growth
- SURG N/A
- ABVC N/A
- EPS
- SURG N/A
- ABVC N/A
- Revenue
- SURG $36,461,935.00
- ABVC $391,242.00
- Revenue This Year
- SURG $20.20
- ABVC $735.18
- Revenue Next Year
- SURG $121.54
- ABVC N/A
- P/E Ratio
- SURG N/A
- ABVC N/A
- Revenue Growth
- SURG N/A
- ABVC 186.84
- 52 Week Low
- SURG $1.05
- ABVC $0.40
- 52 Week High
- SURG $3.47
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- SURG 47.32
- ABVC 46.98
- Support Level
- SURG $2.51
- ABVC $2.99
- Resistance Level
- SURG $2.90
- ABVC $3.33
- Average True Range (ATR)
- SURG 0.15
- ABVC 0.19
- MACD
- SURG -0.02
- ABVC -0.01
- Stochastic Oscillator
- SURG 41.67
- ABVC 13.46
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.